Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase EARLY_PHASE1 2Phase 2 1

Status

Recruiting 4Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 7

Sponsor

Cancer Type

Other solid neoplasm 7

Conditions

Breast Neoplasms 555Lymphoma 447Precursor Cell Lymphoblastic Leukemia-Lymphoma 413Lymphoma, Large B-Cell, Diffuse 348Leukemia 346Multiple Myeloma 336Lymphoma, Non-Hodgkin 317Leukemia, Myeloid, Acute 289Leukemia, Lymphocytic, Chronic, B-Cell 286Lymphoma, Follicular 241Burkitt Lymphoma 217Myelodysplastic Syndromes 211Lymphoma, Mantle-Cell 202Hodgkin Disease 193Recurrence 153Lymphoma, B-Cell, Marginal Zone 142Melanoma 135Lymphoma, Large-Cell, Immunoblastic 116Neoplasms 109Lymphoma, B-Cell 103Neuroblastoma 101Neoplasms, Plasma Cell 99Triple Negative Breast Neoplasms 94Ovarian Neoplasms 94Leukemia, Myelogenous, Chronic, BCR-ABL Positive 91Myeloproliferative Disorders 87Hematologic Neoplasms 87Leukemia, Myeloid, Chronic-Phase 83Leukemia, Myeloid, Accelerated Phase 80Leukemia, Myelomonocytic, Chronic 78

Interventions

pembrolizumab 14Injections 13Paclitaxel 10Nivolumab 10Docetaxel 9Cisplatin 9Capecitabine 9Bevacizumab 8toripalimab 7senaparib 7Fluorodeoxyglucose F18 7Cyclophosphamide 7tislelizumab 6atezolizumab 6Irinotecan 6Fluorouracil 6Gemcitabine 5fludarabine 4apatinib 4Oxaliplatin 4Leucovorin 4Ipilimumab 4spartalizumab 3pertuzumab 3olaparib 3camrelizumab 3Rifampin 3Radiosurgery 3Midazolam 3Itraconazole 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Solid Tumor × Cyclophosphamide × Clear all
NCT04469530 2026-02-27

AflacST1903

Emory University

Phase 2 Recruiting
55 enrolled
Other solid neoplasm

Solid Tumor

NCT06394622 2024-05-01

A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors

Fudan University

Phase 1 Recruiting
12 enrolled
Other solid neoplasm

Solid Tumor

NCT06101082 2024-03-06

A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors

China Medical University, China

Phase 1 Recruiting
9 enrolled
Other solid neoplasm

Solid Tumor

NCT03139370 2023-08-25

Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers

Gilead Sciences

Phase 1 Terminated
16 enrolled
Other solid neoplasm

Solid Tumor

NCT05649618 2022-12-14

TIL Cells for the Treatment of the Advanced Solid Tumors Patients

Fujian Cancer Hospital

Phase EARLY_PHASE1 Unknown
42 enrolled
Other solid neoplasm

Solid Tumor

NCT03733587 2020-05-14

GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors

Genexine, Inc.

Phase 1 Completed
24 enrolled
Other solid neoplasm

Solid Tumor

NCT02446431 2015-05-18

Metronomic

Miller Children's & Women's Hospital Long Beach

Phase EARLY_PHASE1 Recruiting
20 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡